Natarajan Sethuraman, President, Research & Develop: Entrada Therapeutics TRDA Sell · Filed 05/04

Trade details

Type: Insider sale
Amount: $398,708.73
Shares · price: 25,907 sh · $15.39 a share
Held after: 216,317 sh
Stock: Entrada Therapeutics TRDA
Person: Natarajan SethuramanPresident, Research & Develop
Trade date: 26/05/04
Filed: 26/05/04
Days to filing: 0 days

Sold 10.7% of holdings

Share of holding sold: 10.7%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 04/04~06/03

Natarajan Sethuraman's recent trades

Natarajan SethuramanPresident, Research & Develop
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$375.7K
25,907 sh
$375.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$235.8K
11,703 sh
$235.8K
Filed 24/12/03
Traded 24/12/03
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$82.8K
4,088 sh
$82.8K
Filed 24/12/03
Traded 24/12/02
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$2,000
100 sh
$2,000
Filed 24/12/03
Traded 24/11/29
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$54.1K
2,700 sh
$54.1K
Filed 24/11/13
Traded 24/11/13

Natarajan Sethuraman, President — sold $398.7K of Entrada Therapeutics TRDA · 10.7% of holdings · 10b5-1 plan | Whalegun